Flow Cytometry Market to Gain Substantial Growth During the Forecast Period 2022-2028

Posted on 2022-09-12 by researchinsights in Healthcare // 0 Comments

San Francisco, California , USA, Sept 12, 2022 — /EPR Network/ —

Flow Cytometry Industry Overview

The global flow cytometry market size was valued at USD 6.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.9% from 2021 to 2027. Factors such as the high prevalence of targeted diseases and increasing R&D investments in biotechnology, clinical, and life science research are expected to significantly fuel market growth over the forecast period.

Flow cytometry helps in analyzing the expression of cell surface and intracellular molecules. It is used to characterize and define different types of cells in a heterogeneous cell population and facilitates assessing the purity of isolated subpopulations. Rising R&D initiatives by various key players for the development of multicolor assays and advanced reagents for analysis are driving the market. Also, the increasing prevalence of chronic and infectious diseases, including the outbreak of COVID-19, has led to the high growth of the market for flow cytometry. Following the outbreak, numerous research institutes and pharma companies are involved in extensive R&D activities for the development of new vaccines and therapies. This has created a huge demand for flow cytometry solutions for research applications.

Gather more insights about the market drivers, restrains and growth of the Global Flow Cytometry market

Flow cytometry is commonly used for the diagnosis of cancer and immunodeficiency. The increasing prevalence of these diseases is one of the factors expected to drive the market for flow cytometry over the forecast period. In addition, adverse effects of chemotherapy and radiation therapy in cancer treatment have increased preference for autologous and allogeneic stem cell therapies by physicians, thereby positively impacting the growth of this market. According to World Cancer Research Fund International (WCRF) data, around 18 million cancer cases were recorded in 2018 globally. Out of these, around 17,036,901 new cases were diagnosed in that year. The same source reported around 437,033 newly diagnosed leukemia cases in the year 2018. Flow cytometry is useful in the diagnosis and classification of leukemia and facilitates distinguishing between lymphoid and myeloid leukemia.

The biotechnology industry is expected to exhibit significant growth over the forecast period due to increasing healthcare expenditure in developed countries and improving healthcare facilities. An increase in government funding to conduct clinical studies pertaining to in vitro molecular diagnostics is expected to drive the market, as it plays a vital role in the development of new products. Increasing investments in prominent biotech and biopharma companies have led to significant market growth. Chinese investors are increasingly focusing on investing in the European biotech companies as compared to that in the U.S. For instance, in 2019, they invested over USD 400 million in European companies, which is greater in comparison to 2017, where less than USD 100 million was invested. In 2019, out of USD 14.92 billion invested in various life science companies, approximately 64.6% of it has been used by the biotechnology sector.

Flow cytometry instruments are expensive, and, as a result, many developing economies are unable to afford technologically advanced flow cytometers. These instruments cost nearly USD 75,000 to USD 100,000 for a four- to six-color and two-laser instrument, which pose a huge burden on small- and medium-sized hospitals and diagnostic laboratories in developing economies. Thermo Fisher Scientific’s Attune with a two-laser and six-color instrument is available for USD 99,000 in the U.S. Thus, the high cost of equipment is expected to limit the demand for advanced flow cytometers.

Browse through Grand View Research’s Biotechnology Industry Research Reports.

Long Read Sequencing Market – The global long read sequencing market size was valued at USD 1,324.9 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 14.74% from 2022 to 2030.
Cell Reprogramming Market – The global cell reprogramming market size was valued at USD 311.66 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2022 to 2030.

Flow Cytometry Market Segmentation

Grand View Research has segmented the global flow cytometry market on the basis of product, technology, application, end-use, and region:

Flow Cytometry Product Outlook (Revenue, USD Million, 2016 – 2027)
- Instruments
- Reagents & Consumables
- Software
- Accessories
- Services
Flow Cytometry Technology Outlook (Revenue, USD Million, 2016 – 2027)
- Cell-based
- Bead-based
Flow Cytometry Application Outlook (Revenue, USD Million, 2016 – 2027)
- Research
- Industrial
- Clinical
Flow Cytometry End-use Outlook (Revenue, USD Million, 2016 – 2027)
- Commercial Organizations
- Hospitals
- Academic Institutes
- Clinical Testing Labs
Flow Cytometry Regional Outlook (Revenue, USD Million, 2016 – 2027)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)

Key Companies profiled:

Some prominent players in the global Flow Cytometry market include

Danaher Corporation
Becton, Dickinson and Company
Luminex Corporation
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Miltenyi Biotec
Sysmex Corporation
Stratedigm, Inc.
Apogee Flow Systems Ltd.
Sony Biotechnology, Inc.
Thermo Fisher Scientific, Inc.

Order a free sample PDF of the Flow Cytometry Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Matched content

Editor’s pick